Phreesia Past Earnings Performance

Past criteria checks 0/6

Phreesia's earnings have been declining at an average annual rate of -17.3%, while the Healthcare Services industry saw earnings growing at 6.8% annually. Revenues have been growing at an average rate of 25.5% per year.

Key information

-17.3%

Earnings growth rate

8.4%

EPS growth rate

Healthcare Services Industry Growth12.5%
Revenue growth rate25.5%
Return on equity-32.5%
Net Margin-20.4%
Last Earnings Update31 Oct 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Phreesia makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

LSE:0A23 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Oct 24405-83200118
31 Jul 24390-100207117
30 Apr 24374-119216115
31 Jan 24356-137222112
31 Oct 23338-144228108
31 Jul 23319-152228102
30 Apr 23301-16222897
31 Jan 23281-17623291
31 Oct 22262-18523483
31 Jul 22245-18122876
30 Apr 22228-15820865
31 Jan 22213-11817452
31 Oct 21197-8014041
31 Jul 21180-5011132
30 Apr 21164-329326
31 Jan 21149-278323
31 Oct 20140-237721
31 Jul 20134-197120
30 Apr 20130-836719
31 Jan 20125-916319
31 Oct 19118-1025718
31 Jul 19110-1135417
30 Apr 19104-544916
31 Jan 19100-454614
31 Jan 1880-384411

Quality Earnings: 0A23 is currently unprofitable.

Growing Profit Margin: 0A23 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0A23 is unprofitable, and losses have increased over the past 5 years at a rate of 17.3% per year.

Accelerating Growth: Unable to compare 0A23's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0A23 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (3.6%).


Return on Equity

High ROE: 0A23 has a negative Return on Equity (-32.52%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 15:50
End of Day Share Price 2024/12/20 00:00
Earnings2024/10/31
Annual Earnings2024/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Phreesia, Inc. is covered by 24 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joseph VruwinkBaird
Zhilin LongBerenberg
Richard CloseCanaccord Genuity